Manuscripts
Showing 1591 manuscripts.
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384
Citation
Michael P. Dube, M.D., Robert A. Parker, Sc.D., Kathleen Mulligan, Ph.D., Pablo Tebas, M.D., Gregory K. Robbins, M.D., M.P.H., Ronenn Roubenoff, M.D., M.H.S., Steven K. Grinspoon, M.D. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384. Clinical Infectious Diseases. 2007 Jul 01; 45(1):120-6. PMID: 17554712.Year
2007
Journal
Clinical Infectious Diseases
Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations
Citation
B. Healy, Victor DeGruttola, Sc.D., Marcello Pagano. Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations. Biometrics. 2007 Sep 01; 63(3):742-50.Year
2007
Journal
Biometrics
A new approach for 'deep salvage' trials in advanced HIV infection
Citation
Michael M. Lederman, M.D., Veronica Miller, Ph.D., Steven G. Deeks, M.D. A new approach for 'deep salvage' trials in advanced HIV infection. AIDS. 2007 Jul 31; 21(12):1503-6. PMID: 17630543.Year
2007
Journal
AIDS
Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase
Citation
Zixin Hu, Ph.D., Hiroyu Hatano, M.D., M.H.S., Scott Hammond, Danielle Smith, B.S., Mary Wild, R.N., Soumi Gupta, Ph.D., Jeannette M. Whitcomb, Robert C Kalayjian, M.D., Barbara Gripshover, M.D., Daniel R. Kuritzkes, M.D. Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase. Journal of Acquired Immune Deficiency Syndromes. 2007 Aug 15; 45(5):494-500. PMID: 17496561.Year
2007
Journal
Journal of Acquired Immune Deficiency Syndromes
Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease.
Citation
Angel A. Luciano, Michael M. Lederman, M.D., Alice Valentin-Torres, Douglas A. Bazdar, Scott F. Sieg, Ph.D. Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease. Journal of Immunology. 2007 Sep 15; 179(6):3543-9. PMID: 17785788.Year
2007
Journal
Journal of Immunology
A resampling-based approach to multiple testing with uncertainty in phase
Citation
Andrea S. Foulkes, Victor DeGruttola, Sc.D. A resampling-based approach to multiple testing with uncertainty in phase. International Journal of Biostatistics. 2007 Jan 01; 3(1):Article 2. PMID: 22550644.Year
2007
Journal
International Journal of Biostatistics
Predictors of AIDS-related morbidity and mortality in a southern U.S. cohort
Citation
Michael J. Mugavero, M.D., M.H.S., Brian Wells Pence, Ph.D., Kathryn Whetten, Ph.D., M.P.H., Jane Leserman, Ph.D., Marvin Swartz, M.D., Dalene Stangl, Ph.D., Nathan Thielman, M.D., M.P.H. Predictors of AIDS-related morbidity and mortality in a southern U.S. cohort. AIDS Patient Care and STDs. 2007 Sep 01; 21(9):681-90. PMID: 17919095.Year
2007
Journal
AIDS Patient Care and STDs
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection
Citation
J. William Critchfield, Donna Lemongello, Digna H. Walker, Juan C. Garcia, David M. Asmuth, M.D., Richard B. Pollard, M.D., B. L. Shacklett. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. Virology. 2007 Jun 01; 81(11):5460-5471.Year
2007
Journal
Virology
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial- AIDS Clinical Trials Group 328
Citation
Ronald T. Mitsuyasu, M.D., Rebecca S. Gelman, Ph.D., Richard B. Pollard, M.D., Deborah Weng-Cherng, M.S., Alan Landay, Ph.D., John L. Fahey, M.D., Richard C. Reichman, M.D., Alejo Erice, M.D., R. Pat Bucy, M.D., Ph.D., J. Michael Kilby, M.D., Michael M. Lederman, M.D., Carol S. Dukes-Hamilton, M.D., Juan J.L. Lertora, M.D., Ph.D., Becky Stephenson, M.D., Pablo Tebas, M.D., Anne-Marie Duliege, M.D., M.S., Richard B. Pollard, M.D. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial- AIDS Clinical Trials Group 328. Archives of Internal Medicine. 2007 Mar 26; 167(6):597-605. PMID: 17389292.Year
2007
Journal
Archives of Internal Medicine
Factors associated with early study discontinuation in AACTG studies, DACS 200
Citation
Janet Andersen, Sc.D., Robert J. Fass, M.D., Charles van der Horst, M.D. Factors associated with early study discontinuation in AACTG studies, DACS 200. Contemporary Clinical Trials. 2007 Sep 01; 28(5):583-92.Year
2007
Journal
Contemporary Clinical Trials